Parkinson’s disease is a progressive neuro-degenerative disease. That is, the disease progresses as more and more neurons are destroyed. The ideal approach is to catch the disease as early as possible so that full function can be restored. This occurs when there are enough dopaminergic neurons remaining, that when given the proper amount and balance of amino acid precursors, are able to compensate for the damage.
However, without proper intervention, the neurodegenerative process will continue. If enough dopaminergic neurons are destroyed, no amount of amino acids will be able to completely restore proper function. Unfortunately, this often occurs when people with Parkinson’s disease attempt to exhaust all other options before implementing amino acid therapy. While these people benefit greatly from amino acid therapy, most do not achieve complete relief of symptoms due to the extent of the neurodegeneration.
Therefore, a person with Parkinson’s disease should implement a course of properly guided amino acid therapy as soon as possible to obtain optimal results. All other therapy options are associated with a progression of the disease. Unlike the medical approach of using L-DOPA/carbidopa, amino acid therapy needs to be implemented as early as possible to optimally manage the symptoms of Parkinson’s disease.
For more information on Amino Acid Therapy and Parkinson’s, click here.
